BPC-157 Nasal Spray — What We Know So Far
BPC-157 nasal spray products are appearing online. What research exists on intranasal peptide delivery and what is unproven.
There are vendors listing BPC-157 nasal spray on their websites and discussing it online. Don’t be too quick to conclude that this delivery method is well-studied, as we found there is no existing research on BPC-157 that involved intranasal delivery. There is science behind nasal peptide delivery, but it does not involve BPC-157.
BPC-157 Nasal Spray Products Are Appearing
What These Products Claim
Several vendors now sell BPC-157 in nasal spray format, typically as a reconstituted solution in a spray bottle. Product pages describe the nasal route as convenient and potentially faster-acting than other routes. Some imply that nasal delivery provides better absorption. These claims are not supported by any published BPC-157 research.
The Published Research Gap
We searched PubMed for studies on intranasal BPC-157 and found no published research specifically testing this route. All published BPC-157 studies use oral (gavage, drinking water), intraperitoneal injection or subcutaneous injection routes. The nasal spray format is a commercial innovation, not a research-validated delivery method for this peptide.
Intranasal Peptide Delivery, General Science
How Nasal Absorption Works
The nasal mucosa has a thin layer and consists of a richly vascular network, rendering it an effective absorbent for a number of substances. So small peptides can pass through the nasal epithelium and make their way into systemic circulation with ease. The route has been extensively researched and employed for several peptides such as oxytocin, desmopressin and calcitonin. It helps circumvent the first-pass metabolism that occurs in the liver, an important benefit for peptides that are destroyed by hepatic enzymes.
Which Peptides Have Nasal Research (Not BPC-157)
Clinical trials have verified the treatment through the nose for certain peptides. The FDA has approved the Desmopressin nasal spray. Researchers also use the oxytocin nasal spray. The calcitonin nasal spray was FDA-approved for osteoporosis. Each of these treatments had passed the official clinical studies. The BPC-157 treatment still hasn’t had these studies done.
What Is Missing for BPC-157 Specifically
No Published Intranasal Studies
The absence of available information for intranasal use of BPC-157 makes it unclear whether or not BPC-157 is able to penetrate the nasal mucosa, what the amount of the medication is which is delivered through this route compared to injections and orally, whether the compound maintains its efficacy in a spray formulation over time and what local adverse events take place in the nasal passages.
Stability and Formulation Questions
Nasal sprays containing peptides must have a prolonged shelf life at room temperature in liquid form. BPC-157 stability in the spray form has never been reported. The peptide is stable in acidic (pertaining to oral administration) conditions; however, it is questionable whether stability can occur in the neutral pH of a nasal spray formulation. Without data on stability, the amount of peptide in a spray bottle would degrade in ways which are unknown.
FAQ, BPC-157 Nasal Spray
Is there research on BPC-157 nasal spray?
None. In published work so far, intranasal delivery of BPC-157 has never been studied. The commercial nasal spray solutions are based on the common idea of nasal peptide administration, and do not result from research focusing on BPC-157.
How would a nasal spray peptide work?
In fact, nasal peptide drugs administered via sprays allow for absorption through nasal membranes into the bloodstream. This is the mode of action of approved drugs in nasal form such as desmopressin. But the mode of delivery of BPC-157 through the nose has yet to be studied.
Are BPC-157 nasal sprays regulated?
BPC-157 in any form is not FDA approved for human use. Nasal spray products are sold under the same research-use-only framework as vials. Products making health claims for nasal BPC-157 would violate the same FDA regulations that apply to other BPC-157 marketing.
Keep reading
BPC-157 and Gut Health — Research Summary
What animal studies report about BPC-157 and gut health. Gastric protection models, mucosal healing and the evidence gap.
BPC-157 Oral vs. Injection — What Studies Show
BPC-157 oral vs injection routes compared using published animal study data. We cover what researchers observed with each route and what remains unstudied.
Does BPC-157 Work? What the Evidence Says
Does BPC-157 work? We look at what animal studies report, why human data is missing and how to interpret anecdotal claims you find online.
Compare the current picks
Prices, sizes and ratings side by side, updated when the merchant pages change.
See top picks